Company Analysis
Sign in

Harmony Biosciences Holdings, Inc. (HRMY)

Nasdaq: HRMY · Pharmaceutical Preparations · Plymouth Meeting, PA · filing with the SEC since 2020
Full chart Alerts Compare
Grade7.0
◀ Past 8.4● Present 6.9▶ Future 5.6
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Filings

204 filings since 2017 beside 256 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 3, 2026.

Filings a yearinsider forms included
67547362598263
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Oct 30, 2026.SEC letters: 3 in the last 36 months, the newest Apr 15, 2025.
Insider forms 256

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 30, 2026 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Oct 12, 2026
Oct 27, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 13, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Oct 12, 2026
Aug 4, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 31, 2026 SCHEDULE 13G Large holder notice
Jul 28, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 16, 2026 8-K items 2.02, 5.02, 7.01, 9.01 Results released; Officer or director change; Investor disclosure (Regulation FD) · Current report
May 14, 2026 8-K item 5.07 Shareholder vote · Current report
May 7, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 7, 2026 10-Q Quarterly report Mar 31, 2026
Apr 14, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Apr 3, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 3, 2026 DEFA14A Extra proxy material
Apr 3, 2026 DEF 14A Proxy statement May 14, 2026
Apr 2, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Mar 31, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 24, 2026 10-K Annual report Dec 31, 2025
Feb 24, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 5, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 4, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 23, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 24, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jun 11, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 5, 2025 8-K items 8.01, 9.01 Other event · Current report
May 15, 2025 8-K item 5.07 Shareholder vote · Current report
May 6, 2025 10-Q Quarterly report Mar 31, 2025
May 6, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 29, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 15, 2025 UPLOAD SEC comment letter
Apr 9, 2025 CORRESP Reply to the SEC
Apr 4, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 204 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton HRMY · research, not advice